Table 2.
Characteristics of confirmed cases of SCLC following the case validation exercise
| Characteristic | No. of patients N = 381 n (%) |
|---|---|
| Recorded symptoms | 322 (84.5) |
| Haemoptysis | 38 (11.8) |
| Chest infection | 58 (18.0) |
| Cough | 51 (15.8) |
| Shortness of breath | 37 (11.5) |
| Chest, abdominal or back pain | 49 (15.2) |
| COPD/respiratory complications | 41 (12.7) |
| Abnormal weight loss | 13 (4.0) |
| Indirect finding | 35 (10.9) |
| First diagnostic procedure recorded | 278 (73.0) |
| Chest X-ray | 182 (65.5) |
| CAT scan | 49 (17.6) |
| Abdominal ultrasound | 5 (1.8) |
| Bronchoscopy | 33 (11.9) |
| Biopsy | 5 (1.8) |
| Other | 4 (1.4) |
| Stage | |
| Known | 242 (63.5) |
| Limited | 55 (23.7)* |
| Extensive | 187 (76.3)* |
| Unknown | 139 (36.5) |
| Chemotherapy/radiotherapy | |
| Chemotherapy | 212 (55.6) |
| Radiotherapy | 120 (31.5) |
| Metastasis | 144 (37.8) |
| Asbestos exposure | 11 (2.9) |
*Percentage of the 242 cases with recorded stage
Computed tomography scan; CAT, COPD chronic obstructive pulmonary disease, SCLC small cell lung cancer